Clinical Trial Update: The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating curcumin for active lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Ain Shams University | Conditions: Lupus Nephritis, SLE Nephritis | Phase 2 | Status: COMPLETED